Ravi Parikh, MD, MPH: Anti-VEGF Biosimilar Paradox in Ophthalmology

Based on data presented at ARVO 2023, Parikh discusses how anti-VEGF biosimilars may increase both patient and overall healthcare costs.

Related Keywords

Ravi Parikh ,Department Of Ophthalmology ,Association For Research ,Grossman School Of Medicine ,Annual Meeting ,Clinical Assistant Professor ,